SP 4206
CAS No. 515846-21-6
SP 4206( SP4206 )
Catalog No. M14795 CAS No. 515846-21-6
SP 4206 is a high-affinity (Kd=70 nM) small molecule that blocks blocks the binding of the IL-2α receptor (IL-2Rα) to IL-2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1116 | Get Quote |
|
| 50MG | 3222 | Get Quote |
|
| 100MG | 4410 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSP 4206
-
NoteResearch use only, not for human use.
-
Brief DescriptionSP 4206 is a high-affinity (Kd=70 nM) small molecule that blocks blocks the binding of the IL-2α receptor (IL-2Rα) to IL-2.
-
DescriptionSP 4206 is a high-affinity (Kd=70 nM) small molecule that blocks blocks the binding of the IL-2α receptor (IL-2Rα) to IL-2; targets virtually the same critical "hot-spot" residues on IL-2 that drive binding of IL-2Rα.
-
In VitroSP4206 binds the WT IL-2, IL-2 variant K35L/M39V, IL-2 variant P65A, and IL-2 variant V69A with EC50s of 68.8, 80.1, 117.0, and 10.4 nM, respectively.
-
In Vivo——
-
SynonymsSP4206
-
PathwayApoptosis
-
TargetIL Receptor
-
RecptorInterleukin Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number515846-21-6
-
Formula Weight662.57
-
Molecular FormulaC30H37Cl2N7O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (150.93 mM)
-
SMILESO=C(C1=CC=C(COC2=CC=C(C3=NN(C)C(C4CCN(C(CNC([C@H](/N=C(N)\N)CC(C)C)=O)=O)CC4)=C3)C(Cl)=C2Cl)O1)O
-
Chemical Name5-[[2,3-dichloro-4-[5-[1-[2-[[(2R)-2-(diaminomethylideneamino)-4-methylpentanoyl]amino]acetyl]piperidin-4-yl]-1-methylpyrazol-3-yl]phenoxy]methyl]furan-2-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Arkin MR, et al. Chem Biol. 2014 Sep 18;21(9):1102-14.
2. Thanos CD, et al. Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15422-7.
molnova catalog
related products
-
Abrezekimab
Abrezekimab (VR 942) is composed of CDP7766, leucine, and trehalose. Abrezekimab is a humanized antibody that targets human IL-13.
-
Ustekinumab
Ustekinumab is an anti-IL-12/IL-23 IgG1κ human monoclonal antibody.
-
Kansuinine A
Kansuinine A, a 95% ethanol extract from the roots of E. kansui, possesses an inhibitory effect on IL-6-induced Stat3 activation by activating ERK1/2.
Cart
sales@molnova.com